Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Price of propofol injection?Ubrogepant ema approval europe status 2025?Levofloxacin hemihydrate prices?Cost of leucovorin without insurance?Generic for briviact?
Aklief (tr e t i n o i n 0.005% cream) has reached Phase 3 clinical development in the United States. [1]
DrugPatentWatch.com lists aklief’s development status as Phase 3 for the product in the U.S. clinical development pathway. [1]
Reaching Phase 3 typically means the drug has been tested in large patient populations to assess effectiveness and safety more definitively than earlier phases, which is a common step toward regulatory review and approval.
[1] https://www.drugpatentwatch.com/p/aklief
Other Questions About Clinical :